| Can glucosamine alleviate knee pain?
Glucosamine sulphate is a sulphur-containing amino sugar
that occurs naturally in connective tissue and cartilage. It stimulates
the cells that are involved in the production of new bone and cartilage
and therefore has a role in maintaining the mobility, strength and integrity
of joint structures.
The effects of oral glucosamine supplementation
on knee pain were recently examined in a trial at the University of
Western Australia. The study involved randomly supplementing 46 subjects
with either glucosamine or placebo over a 12 week period. During this
time changes in knee pain and function were assessed 4 times using both
clinical and functional tests and participant subjective evaluations.
The tests carried out in the study involved
joint line palpation, a "duck walk" over a distance of 3 metres, a repeated
stair climb (walking pace) and the completion of two questionnaires
- the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Knee
Pain Scale (KPS).
The results of the clinical and functional
tests showed improvement over the 12-week period but without any significant
difference between the two groups. The results of the questionnaires
also showed improvement with time, but the glucosamine group was found
to have significantly better KOOS quality of life scores at the third
(after 8 weeks) and final (after 12 weeks) testing sessions, and lower
KPS scores at week eight, when compared to the placebo group.
The results of the participant subjective
evaluations suggested a significant difference between the two groups
with favourable results for glucosamine supplementation. 21 of the 24
subjects (88%) in the glucosamine group reported improvement in their
knee pain compared with only 3 out of 22 subjects (17%) in the placebo
group.
In conclusion the authors suggest that
taking a glucosamine supplement may reduce pain and improve function
in persons who experience regular knee pain, possibly caused by previous
cartilage damage or osteoarthritis.
Br J Sports Med 2003 Feb; 37(1):45-9;
discussion 49
|